Meet the Experts in Non-Alcoholic SteatoHepatitis (NASH) and Comorbid Conditions
Welcome to our comprehensive list of esteemed authors who specialize in Non-Alcoholic SteatoHepatitis (NASH) and associated comorbid conditions. These distinguished professionals have dedicated their careers to advancing research, treatment, and education in the field of hepatology, with a focus on NASH. They have made significant contributions to the understanding and management of this complex liver disease, as well as its related conditions. Explore their individual bios to learn more about their accomplishments, research interests, and publications. Join us in celebrating these exceptional individuals and their ongoing commitment to improving the lives of those affected by NASH and related health issues.
Prof. Jérôme Boursier
Prof. Jerome Boursier (MD, PhD) is an esteemed hepatologist and researcher from Angers University
Prof. Stéfan Darmoni
Prof. Stéfan Darmoni is a pathologist and medical informatics expert, currently a professor at the University of Rouen in France. He is renowned for his contributions to the field of clinical decision support and his innovative approaches to diagnosing and treating diseases using advanced technologies.
Professor Byrne trained as a clinical scientist in the UK and the US, at Cardiff, Cambridge and Stanford Universities. He undertook a PhD studying liver lipid metabolism at Cambridge University. He was a post-doctoral fellow at Stanford University and then an MRC fellow at Cambridge University.
Dr Giada Sebastiani
Dr. Giada Sebastiani is an Associate Professor of Medicine and Hepatologist at McGill University, with expertise in chronic liver diseases, NAFLD, and hepatitis C. She is an accomplished author and speaker with an h-index of 38 and has contributed valuable knowledge to our website, PanNash.
Dr Romero Gomez
Dr. Manuel Romero Gómez is a renowned hepatology expert and Full-Professor of Medicine at the University of Seville, Spain. As the Chief of the Digestive Diseases Department at Virgen del Rocío University Hospitals, he leads significant research projects in liver diseases. With over 340 publications and numerous awards, Dr. Romero Gómez is a prominent figure in the field of gastrointestinal and liver diseases.
Dr. Vlad Ratziu
Vlad Ratziu, MD, PhD is professor of hepatology at the Sorbonne Université and the Hôpital Pitié-Salpêtrière Medical School in Paris, France since 2004.
Dr Maarten E. Tushuizen
Prof. Maarten Tushuizen provides a comprehensive review on Non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) and why it is a multisystem disease and further goes on to evaluate their connection to type 2 diabetes mellitus (T2DM) and cardiovascular disease. He also delves into the next steps of managing and diagnosing NASH and NAFLD.
Prof. Marat Fudim
Dr. Marat Fudim is a distinguished heart failure cardiologist at Duke University Medical Center, holding the role of Medical Director for both the Heart Failure Research Unit and Heart Failure Remote Monitoring.
Michael Betel is a leading patient advocate and educator in the field of liver diseases, specifically non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), serving as the Director of the Fatty Liver Alliance.
Prof. M. F. Abdelmalek
Manal F. Abdelmalek, MD, MPH is Director of Hepatology and institutional lead for investigator-initiated and industry-sponsored multicenter clinical studies, Mayo Clinic, USA. Until recently, she was tenured Professor of Medicine in the Division of Gastroenterology and Hepatology at...
Prof. Frank M. Sacks
Dr. Sacks is Professor of Cardiovascular Disease Prevention in the Nutrition Department of Harvard Chan School of Public Health; Professor of Genetics & Complexes Diseases; and Professor of Medicine at Harvard Medical School. Dr. Sacks led the panel designing the DASH Study, which crafted a healthful eating pattern and demonstrated..
Prof. Sven Francque
Prof. Dr. Sven Francque obtained his MD at the University of Antwerp, Belgium, in 1994 and was subsequently trained in internal medicine and in gastroenterology and hepatology at the Antwerp University Hospital, Belgium and at the Department of Hepatology of the Beaujon hospital, Clichy, France.
Prof. Arun Sanyal
Learn from the expertise of Professor Arun Sanyal, a distinguished hepatologist and professor of medicine at Virginia Commonwealth University. Discover his valuable insights on NASH and liver fibrosis through his video contributions to PanNash.
Prof. Francois Dufour
Prof. Jean-François Dufour studied mathematics at the University of Geneva, Switzerland, and received his medical degree from the Geneva Medical School. After training in internal medicine at the University Hospital Geneva and the University Hospital Bern, he joined the laboratory of Professor
Prof. Frank Tacke
Frank Tacke was originally educated at the medical school in Hannover, Germany, and Baylor College of Medicine, Houston, TX. Later he stayed at University of Texas, M.D. Anderson Cancer Center in Houston, working on new gene therapy strategies (1998-1999) as well as for a post-doctoral research training (2004-2006) at the Mount Sinai Medical Center, New York, working on monocyte/macrophage and dendritic cell biology. Since 2006, he is a clinical physician and leader of a research laboratory at the University Hospital Aachen, Germany.
Prof. Kenneth Cusi
Dr. Cusi is a Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at The University of Florida at Gainesville (2011-present). He is also a faculty and researcher at the Endocrinology, Diabetes and Metabolism Division at the Veterans Administration Medical Center at...
Prof. Laurent Castera
Laurent Castera (MD, PhD) is Professor of Hepatology at the University of Paris-VII (Department of Hepatology, Hopital Beaujon, Clichy, France) and Visiting Professor of Medicine in University College of London (Institute of Liver and Digestive Health, Royal Free Hospital London, UK).
Prof. Michael Roden
Professor Dr. Michael Roden is Chair of Endocrinology and Metabolic Diseases, Heinrich-Heine University, Director of the Division of Endocrinology and Diabetology, University Clinics Düsseldorf and CEO of the German Diabetes Center (DDZ). He was trained at University of Vienna and Yale University. His translational studies..
Prof. Dr. Jörn M. Schattenberg
Metabolic Liver Research Program, University Medical Center Mainz Bestätigte
Prof. Gyongyi Szabo
Gyongyi Szabo, MD, PhD is the Worcester Foundation for Biomedical Research Endowed Chair, Professor and Vice Chair of Medicine and Associate Provost at the University of Massachusetts Medical School. Dr. Szabo is an internationally recognized leader in the field of liver immunology and inflammation.
Dr. Scott Friedman
Dr. Scott L. Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai.
Prof. Stephen Harrison
With over 20 years in the industry, Dr. Harrison has formed a multitude of global and local relationships with like-minded physicians and experts to raise awareness of liver disease and find a treatment for the patients that need it most.
Dr. Wilhelmus Kwanten
⚕️Dr. Wilhelmus Kwanten (Belgium) practices at the University Hospital Antwerp (UZA).